Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Pacira BioSciences, Inc. | 60,000 | reported | 03 Jan 2018 | tx 10+226,250−768 |
| ATAI Life Sciences N.V. | 56,818 | reported | 04 Nov 2025 | tx 3+365,818 |
| Caribou Biosciences, Inc. | 45,000 | reported | 20 Feb 2026 | tx 5+174,000 |
| Alaunos Therapeutics, Inc. | 31,780 | reported | 31 Dec 2019 | tx 3+208,480 |
| TREVENA INC | 13,700 | reported | 13 Jun 2024 | tx 7+350,080 |
| Protara Therapeutics, Inc. | 9,000 | reported | 09 Jun 2020 | tx 10+114,564 |
| Esperion Therapeutics, Inc. | 5,019 | reported | 29 May 2019 | tx 5+57,067 |
| RAPT Therapeutics, Inc. | 0 | reported | 03 Mar 2026 | tx 4+29,956−29,956 |
| MARINUS PHARMACEUTICALS INC | 0 | reported | 11 Feb 2025 | tx 32+4,796,563−2,404,980 |
| CONSTELLATION PHARMACEUTICALS INC | 0 | reported | 15 Jul 2021 | tx 6+52,684−52,684 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Mar 2026 | TENDER | RAPT Therapeutics, Inc. | 4,956 | — | |
| 03 Mar 2026 | OTHER | RAPT Therapeutics, Inc. | 25,000 | — | deriv |
| 20 Feb 2026 | GRANT_AWARD | Caribou Biosciences, Inc. | 45,000 | 0.00 USD | deriv |
| 30 Jan 2026 | GRANT_AWARD | RAPT Therapeutics, Inc. | 4,956 | 0.00 USD | |
| 04 Nov 2025 | GRANT_AWARD | ATAI Life Sciences N.V. | 56,818 | 0.00 USD | deriv |
| 26 Jun 2025 | GRANT_AWARD | ATAI Life Sciences N.V. | 103,000 | 0.00 USD | deriv |
| 21 Jun 2025 | GRANT_AWARD | RAPT Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 20 Feb 2025 | GRANT_AWARD | Caribou Biosciences, Inc. | 40,500 | 0.00 USD | deriv |
| 11 Feb 2025 | OTHER | MARINUS PHARMACEUTICALS INC | 179,536 | 0.55 USD | |
| 07 Feb 2025 | OTHER | MARINUS PHARMACEUTICALS INC | 125,064 | 0.55 USD | |
| 14 Aug 2024 | PURCHASE | MARINUS PHARMACEUTICALS INC | 5,933 | 1.10 USD | first after silence |
| 11 Feb 2025 | OTHER | MARINUS PHARMACEUTICALS INC | 193,050 | 0.00 USD | deriv |
| 11 Feb 2025 | OTHER | MARINUS PHARMACEUTICALS INC | 290,000 | 0.00 USD | deriv |
| 11 Feb 2025 | OTHER | MARINUS PHARMACEUTICALS INC | 450,000 | 0.00 USD | deriv |
| 11 Feb 2025 | OTHER | MARINUS PHARMACEUTICALS INC | 200,000 | 0.00 USD | deriv |
| 11 Feb 2025 | OTHER | MARINUS PHARMACEUTICALS INC | 15,917 | 0.00 USD | deriv |
| 11 Feb 2025 | OTHER | MARINUS PHARMACEUTICALS INC | 7,500 | 0.00 USD | deriv |
| 11 Feb 2025 | OTHER | MARINUS PHARMACEUTICALS INC | 167,825 | 0.00 USD | deriv |
| 11 Feb 2025 | OTHER | MARINUS PHARMACEUTICALS INC | 335,650 | 0.00 USD | deriv |
| 11 Feb 2025 | OTHER | MARINUS PHARMACEUTICALS INC | 360,000 | 0.00 USD | deriv |
| 05 Aug 2024 | SALE | MARINUS PHARMACEUTICALS INC | 12,145 | 1.13 USD | |
| 18 Jun 2024 | GRANT_AWARD | MARINUS PHARMACEUTICALS INC | 37,300 | 0.00 USD | |
| 18 Jun 2024 | GRANT_AWARD | MARINUS PHARMACEUTICALS INC | 167,825 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | TREVENA INC | 13,700 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | ATAI Life Sciences N.V. | 206,000 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 14 Aug 2024.